Huge opportunities emerge through the use of patient health and disease data. However, it is extremely difficult to materialize value from such data. Is the root cause legislation like GDPR, data governance impairment, data interoperability impairment, wrong financial incentivations, non machine readable based documentation or are the expectations and promises not realistic?
The usage of data can be in the context of research, medical treatment as well as administrative tasks. Overall it can lead to outcome improvements and reduce the financial burden of health services to the society.
We open the discussion and would like to invite you to debate how patient data should be used.